Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
Tectonic Therapeutic plans a fireside chat and one-on-one investor meetings at the Morgan Stanley Global Healthcare Conference with webcast and replay access.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tectonic Therapeutic (TECX) will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026 in New York, NY.
President and CEO Alise Reicin, MD, is scheduled for a fireside chat at 5:35 PM ET, which will be webcast live and accessible via the Investors section of the company’s website. A replay will be available for approximately 90 days, and management will also hold one-on-one investor meetings during the conference.
Details
News Market Reaction – TECX
On Sep 3, the day this news came out, TECX closed 1.51% below the previous close.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Conference edition
- 24th annual
- Morgan Stanley Global Healthcare Conference
- Conference date
- September 14, 2026
- Fireside chat
- Event time
- 5:35 PM ET
- September 14, 2026
- Replay availability
- approximately 90 days
- Company website after the live event
Historical Context
-
Reported Q2 results, APEX enrollment completion, TX2100 dosing, and cash runway into Q1 2029.
-
Completed enrollment in 24-week APEX Phase 2 trial across 14 countries.
-
Reported Q1 results, pipeline progress, leadership additions, and cash runway into Q4 2028.
-
Appointed Jessica Chutter to board, effective June 8, 2026, citing healthcare banking experience.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
gpcrs technical
g-protein coupled receptors technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
WATERTOWN, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will participate in a fireside chat at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference.
Morgan Stanley 24th Annual Global Healthcare Conference
| Date: | September 14, 2026 |
| Time: | 5:35 PM ET |
| Location: | New York, NY |
| Format: | Fireside Chat |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
The live fireside chat can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. Once the live event has concluded, a replay of the event will be available on the Company’s website for approximately 90 days.
The Tectonic management team will host one-on-one meetings during the conference. Interested investors should contact their Morgan Stanley representative to schedule meetings.
About Tectonic
Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow us on LinkedIn.
Contacts: Investors: Dan Ferry LifeSci Advisors (617) 430-7576 daniel@lifesciadvisors.com Media: Kathryn Morris The Yates Network (914) 204-6412 kathryn@theyatesnetwork.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.